What is the best treatment approach for an elderly patient with delirium, restlessness, confusion, and attempts to get out of bed who is at high risk of falls?

Management of Restlessness, Confusion, and Fall Risk in Elderly Patients

The best treatment approach is a multicomponent nonpharmacologic intervention delivered by an interdisciplinary team, focusing on identifying and treating reversible medical causes, environmental modifications, and behavioral strategies—medications should be reserved only for severe agitation threatening substantial harm after behavioral interventions have failed.

Immediate Priority: Systematic Investigation of Reversible Medical Causes

Before any intervention, you must systematically evaluate and treat underlying medical contributors that commonly drive behavioral disturbances in elderly patients who cannot verbally communicate discomfort 1:

• Pain assessment and management is the single most important contributor to behavioral disturbances and must be addressed first 1
• Infection screening is mandatory—check for urinary tract infections and pneumonia, as these are disproportionately common triggers of acute confusion and agitation 1
• Metabolic disturbances including hypoxia, dehydration, electrolyte abnormalities, hyperglycemia must be evaluated and corrected 1
• Constipation and urinary retention significantly contribute to restlessness and must be systematically assessed 1
• Medication review to identify and discontinue anticholinergic agents (diphenhydramine, oxybutynin, cyclobenzaprine) that worsen confusion and agitation 1

First-Line Treatment: Multicomponent Nonpharmacologic Interventions

These interventions can prevent approximately one-third of delirium cases and are cost-effective compared to usual care 1:

Environmental Modifications

• Ensure adequate lighting throughout the day and especially during late afternoon/evening to reduce visual misinterpretations 1
• Reduce excessive noise and provide a calm, quiet environment to minimize overstimulation 1
• Install safety equipment including grab bars, handrails, and remove hazardous items to prevent falls 1
• Simplify the environment with clear labels, color-coded storage, and structured layouts to reduce confusion 1

Communication and Orientation Strategies

• Use calm tones, simple one-step commands, and gentle touch for reassurance rather than complex multi-step instructions 1
• Allow adequate time for the patient to process information before expecting a response 1
• Frequently reassure and reorient the patient, carefully explaining all activities 1
• Maintain consistency of caregivers and minimize relocations, as constant moving disrupts orientation 1

Activity and Sleep-Wake Cycle Optimization

• Early mobilization and walking with at least 30 minutes of supervised mobility daily 1
• Ensure at least 30 minutes of sunlight exposure daily to provide temporal cues and regulate circadian rhythm 1
• Nonpharmacologic approaches to sleep including predictable bedtime routines and reducing time in bed during the day 1
• Structured daily routines for meals, exercise, and activities to reduce confusion and anxiety 1

Sensory and Nutritional Support

• Adaptive equipment for vision and hearing impairment to maintain sensory input 1
• Maintaining nutrition and hydration as dehydration worsens confusion 1

Fall Prevention Strategies (Without Restraints)

Physical restraints should be minimized as they can worsen agitation and increase fall risk 1, 2:

• Supervised mobility with staff or family presence rather than restraints 1
• Low bed height with floor mats beside the bed to reduce injury risk 1
• Bed/chair alarms to alert staff when the patient attempts to get up 1
• Frequent toileting schedule to address a common reason for getting out of bed 1
• Encourage family and friends to stay at bedside and bring familiar objects from home 1

When Pharmacologic Treatment May Be Considered

Medications should ONLY be used when the patient is severely agitated, distressed, or threatening substantial harm to self or others, AND behavioral interventions have been thoroughly attempted and documented as insufficient 1:

For Severe Acute Agitation (Imminent Risk of Harm)

• Haloperidol 0.5–1 mg orally or subcutaneously is the preferred first-line option, with a strict maximum of 5 mg per 24 hours in elderly patients 1, 3
• Higher initial doses (>1 mg) provide no additional benefit and significantly increase adverse effects including sedation and extrapyramidal symptoms 1
• Daily in-person examination is mandatory to evaluate ongoing need and assess for side effects 1
• Use the lowest effective dose for the shortest possible duration, with a goal to taper within 3–6 months 1

Critical Safety Warnings for Antipsychotics

• All antipsychotics increase mortality risk 1.6–1.7 times higher than placebo in elderly dementia patients—this must be discussed with surrogates before initiation 1, 3
• Cardiovascular risks include QT prolongation, dysrhythmias, sudden death, and hypotension 1
• Other serious adverse effects include falls, pneumonia, extrapyramidal symptoms, and metabolic changes 1
• Patients over 75 years respond less well to antipsychotics, particularly olanzapine 1, 3

What NOT to Use

• Benzodiazepines should NOT be used as first-line treatment for agitated delirium (except for alcohol or benzodiazepine withdrawal) because they increase delirium incidence and duration, cause paradoxical agitation in approximately 10% of elderly patients, and increase fall risk 1, 4
• Cholinesterase inhibitors should NOT be newly prescribed to prevent or treat delirium, as they have been associated with increased mortality 1
• Anticholinergic medications (diphenhydramine, hydroxyzine) worsen confusion and agitation and must be avoided 1

For Chronic Agitation (Not Acute Crisis)

If behavioral symptoms persist beyond the acute phase and are not immediately dangerous, SSRIs are the preferred first-line pharmacologic option 3:

• Citalopram 10 mg daily (maximum 40 mg) or Sertraline 25–50 mg daily (maximum 200 mg) 3
• Evaluate response within 4 weeks using quantitative measures; if no clinically significant response, taper and withdraw 1, 3
• SSRIs significantly reduce overall neuropsychiatric symptoms, agitation, and depression in patients with cognitive impairment 3

Common Pitfalls to Avoid

• Do NOT add medications without first addressing reversible medical causes (pain, infection, metabolic issues)—this is the most common error 1, 3
• Do NOT continue antipsychotics indefinitely—approximately 47% of patients continue receiving them after discharge without clear indication 1
• Do NOT use antipsychotics for mild agitation or behaviors like unfriendliness, poor self-care, repetitive questioning, or wandering—these are unlikely to respond 1
• Do NOT combine high-dose benzodiazepines with antipsychotics—this combination has resulted in fatal respiratory depression 1
• Do NOT use physical restraints routinely—they worsen agitation and increase fall risk 1, 2

Implementation Requirements

The challenge is not the complexity of individual interventions but achieving high fidelity—doing all of these things all the time to all patients who are at risk 1:

• Ongoing educational programs for healthcare professionals regarding delirium recognition and management 1
• Interdisciplinary team approach with nursing, physical therapy, pharmacy, and physician collaboration 1
• System-level support for comprehensive and reliable delivery of nonpharmacologic interventions 1
• Daily reassessment of the need for any pharmacologic interventions with in-person examination 1